What amount sold does Regenerative Medical Solutions, Inc. report in Form D filings?

The latest linked filings report $7M sold across 5 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Regenerative Medical Solutions, Inc.'s most recent SEC filing?

Regenerative Medical Solutions, Inc.'s most recent Form D filing was on 2023-08-28.

How many investors does Regenerative Medical Solutions, Inc. have?

The most recent Form D filing lists 2 investor(s).

What type of securities does Regenerative Medical Solutions, Inc. offer?

Regenerative Medical Solutions, Inc.'s SEC Form D filings indicate equity offerings.

Regenerative Medical Solutions, Inc.

CIK: 0001579613·Biotechnology·Madison, WI·Corporation

Reported Sold

$7,001,000

Total Filings

Identified Offerings

Last Filed

Aug 28, 2023

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Aug 28, 2023Form D — New notice

Reported sold: $5,000,000 · Target: Indefinite

Rule 506(b)·2 investors

Aug 14, 2018Form D — New notice

Reported sold: $181,000 · Target: $3,000,000

Rule 506(b)·1 investor

Nov 7, 2014Form D — New notice

Reported sold: $375,000 · Target: $3,000,000

Rule 506(b)·1 investor

Jul 18, 2014Form D/A — Amendment

Reported sold: $595,000 · Target: $1,000,000

Rule 506(b)·9 investors

Changed: Exemptions

Feb 10, 2014Form D — New notice

Reported sold: $595,000 · Target: $1,000,000

Rule 506(c)·9 investors

Jun 20, 2013Form D — New notice

Reported sold: $850,000 · Target: $850,000

Rule 506·2 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

17%

Latest reported sold across 5 identified offerings

$7,001,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Anthony D. Kolton

Related Person

Appears on 5 filings

Guy Tagliavia

Related Person

Appears on 3 filings

Thomas P. Joyce

Related Person

Appears on 2 filings

Gary Gorman

Related Person

Appears on 2 filings

Jon S. Odorico, MD, FACS

Related Person

Appears on 2 filings

Thomas Joyce

Related Person

Appears on 1 filing

Anthony D. Kolton

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 28, 2023	New	Indefinite	$5,000,000	2
Aug 14, 2018	New	$3,000,000	$181,000	1
Nov 7, 2014	New	$3,000,000	$375,000	1
Jul 18, 2014	Amendment	$1,000,000	$595,000	9
Feb 10, 2014	New	$1,000,000	$595,000	9
Jun 20, 2013	New	$850,000	$850,000	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

CellTrack Corp

Biotechnology

Offering target: $600,000

Filed Jul 16, 2026